Literature DB >> 2490852

Proteoglycan: collagen interactions in dermatosparactic skin and tendon. An electron histochemical study using cupromeronic blue in a critical electrolyte concentration method.

J E Scott1, M Haigh, B Nusgens, C M Lapière.   

Abstract

Proteoglycans (PGs), stained for electron microscopy with Cupromeronic blue, were observed in skin and tendon from normal and dermatosparactic calves. Very frequently they (i.e. dermatan sulphate (DS) PGs) were seen arrayed orthogonally to the collagen fibrils, in the gap zone, usually at the d band, in both diseased and normal tissues. Where UO2(2+) staining showed regular and normal packing of collagen molecules, orthogonally located DS PGs were seen. No qualitative differences between controls and pathological tissues were identified, but quantitatively it appears likely that considerable areas of the surface of dermatosparactic skin collagen fibrils may be without associated PGs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2490852     DOI: 10.1016/s0934-8832(11)80012-0

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  4 in total

Review 1.  Extracellular matrix, supramolecular organisation and shape.

Authors:  J E Scott
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

2.  Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Authors:  K G Danielson; H Baribault; D F Holmes; H Graham; K E Kadler; R V Iozzo
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

3.  Influence of cyclic strain and decorin deficiency on 3D cellularized collagen matrices.

Authors:  Zannatul Ferdous; Luis D Lazaro; Renato V Iozzo; Magnus Höök; Kathryn J Grande-Allen
Journal:  Biomaterials       Date:  2008-04-03       Impact factor: 12.479

4.  Effects of microcurrent stimulation on hyaline cartilage repair in immature male rats (Rattus norvegicus).

Authors:  Carla de Campos Ciccone; Denise Cristina Zuzzi; Lia Mara Grosso Neves; Josué Sampaio Mendonça; Paulo Pinto Joazeiro; Marcelo Augusto Marretto Esquisatto
Journal:  BMC Complement Altern Med       Date:  2013-01-19       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.